Literature DB >> 10921591

Endotracheal surfactant atomization: an alternative to bolus instillation?

M H Wagner1, H Amthauer, J Sonntag, F Drenk, H W Eichstädt, M Obladen.   

Abstract

OBJECTIVE: To investigate the effect of an intratracheal surfactant fog on oxygenation, blood pressure, distribution, and recovery rate as a pilot study to intratracheal surfactant aerosol.
DESIGN: Prospective, randomized study.
SETTING: University laboratory.
SUBJECTS: A total of 15 New Zealand White rabbits.
INTERVENTIONS: The anesthetized ventilated rabbits were surfactant-deprived by repeated lung lavages and then received 200 mg/kg of a 99mTc-labeled porcine surfactant (Curosurf) either as bolus or as intratracheal surfactant fog.
MEASUREMENTS AND MAIN RESULTS: Blood gases and pressure were measured and distribution as well as recovery rate of the surfactant determined by means of the radio label (gamma camera images and lung processing with subsequent gamma counter measurements). Respiratory function normalized immediately, no difference could be found between the two groups with regard to PaO2, PaCO2, and blood pressure. Even distribution of the radiolabel was found with both methods, the bolus group showing a higher percentage of lung pieces with label concentrations of double average or more. Recovery rates were 82.5%+/-13.1% (mean +/- SD) in the bolus group and 86.5%+/-7.7% in the fog group.
CONCLUSION: Endotracheal surfactant fog application is as effective as bolus instillation and may have a role in the treatment of adult respiratory distress syndrome. It has to be considered as a first step in producing an effective aerosol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921591     DOI: 10.1097/00003246-200007000-00058

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.

Authors:  Matthias C Hütten; Elke Kuypers; Daan R Ophelders; Maria Nikiforou; Reint K Jellema; Hendrik J Niemarkt; Carola Fuchs; Markus Tservistas; Roberta Razetti; Federico Bianco; Boris W Kramer
Journal:  Pediatr Res       Date:  2015-08-31       Impact factor: 3.756

Review 2.  Aerosol delivery to ventilated newborn infants: historical challenges and new directions.

Authors:  Jan Mazela; Richard A Polin
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

3.  Intratracheal atomized surfactant provides similar outcomes as bolus surfactant in preterm lambs with respiratory distress syndrome.

Authors:  Ilaria Milesi; David G Tingay; Emanuela Zannin; Federico Bianco; Paolo Tagliabue; Fabio Mosca; Anna Lavizzari; Maria Luisa Ventura; C Elroy Zonneveld; Elizabeth J Perkins; Don Black; Magdy Sourial; Raffaele L Dellacá
Journal:  Pediatr Res       Date:  2016-03-08       Impact factor: 3.756

Review 4.  Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.

Authors:  Federico Bianco; Fabrizio Salomone; Ilaria Milesi; Xabier Murgia; Sauro Bonelli; Elena Pasini; Raffaele Dellacà; Maria Luisa Ventura; Jane Pillow
Journal:  Respir Res       Date:  2021-02-26

5.  Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial.

Authors:  Stefan Minocchieri; Clare A Berry; J Jane Pillow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2018-07-26       Impact factor: 5.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.